Alpha-Beta Technologies

Alpha & Beta Technologies is a private biotechnology company focused on regenerative medicine, cell therapy, clinical trials, and transplant-related products and services. The company describes itself as developing stem cell- and exosome-based approaches intended to address underlying disease causes rather than symptom management. Its website highlights research in hair follicle stem cells, adipose stem cells, amniomembrane-derived cells, and exosome services, alongside autologous stem cell banking offerings. It also lists clinical interests in heart disease, diabetes, liver disease, hair growth, and immune balance, and markets products spanning bone graft, artificial skin, wound-healing aids, cosmetic filler, and hair-growth formulations. Overall, the company appears to operate at the intersection of regenerative medicine services, translational clinical activity, and biologic/tissue-based product development.